{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:50:34Z","timestamp":1791114634370,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.it.2006.05.007","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T03:34:33Z","timestamp":1149651273000},"page":"308-312","source":"Crossref","is-referenced-by-count":84,"title":["CCR5: no longer a \u2018good for nothing\u2019 gene \u2013 chemokine control of West Nile virus infection"],"prefix":"10.1016","volume":"27","author":[{"given":"Jean K.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2006.05.007_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/smim.2001.0345","article-title":"Chemokines in rapid leukocyte adhesion triggering and migration","volume":"14","author":"Johnston","year":"2002","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.it.2006.05.007_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002810000052","article-title":"Chemokines and their receptors in infectious disease","volume":"22","author":"McDermott","year":"2000","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.it.2006.05.007_bib3","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1126\/science.272.5270.1955","article-title":"CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1","volume":"272","author":"Alkhatib","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.it.2006.05.007_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/381667a0","article-title":"HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5","volume":"381","author":"Dragic","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.it.2006.05.007_bib5","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.272.5263.872","article-title":"HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor","volume":"272","author":"Feng","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.it.2006.05.007_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-5793(01)02370-5","article-title":"Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood-stage infection","volume":"495","author":"Michon","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.it.2006.05.007_bib7","doi-asserted-by":"crossref","first-page":"13973","DOI":"10.1073\/pnas.96.24.13973","article-title":"Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea","volume":"96","author":"Zimmerman","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2006.05.007_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease","volume":"17","author":"Berger","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2006.05.007_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.emboj.7600947","article-title":"HIV and the chemokine system: 10 years later","volume":"25","author":"Lusso","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.it.2006.05.007_bib10","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1126\/science.273.5283.1856","article-title":"Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study","volume":"273","author":"Dean","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.it.2006.05.007_bib11","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1021\/bi952950g","article-title":"Molecular cloning and functional expression of a new human CC-chemokine receptor gene","volume":"35","author":"Samson","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.it.2006.05.007_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03401665","article-title":"Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk","volume":"3","author":"Zimmerman","year":"1997","journal-title":"Mol. Med."},{"key":"10.1016\/j.it.2006.05.007_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.GIM.0000127274.45301.54","article-title":"Association of CCR5 delta32 deletion with early death in multiple sclerosis","volume":"6","author":"Gade-Andavolu","year":"2004","journal-title":"Genet. Med."},{"key":"10.1016\/j.it.2006.05.007_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1600-0404.2003.00233.x","article-title":"Increase in CCR5 \u039432\/\u039432 genotype in multiple sclerosis","volume":"109","author":"Pulkkinen","year":"2004","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.it.2006.05.007_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1176\/appi.ajp.163.3.507","article-title":"Association between the CCR5 32-bp deletion allele and late onset of schizophrenia","volume":"163","author":"Rasmussen","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.it.2006.05.007_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1286-4579(02)01618-0","article-title":"Role of G-protein-coupled signaling in the induction and regulation of dendritic cell function by Toxoplasma gondii","volume":"4","author":"Aliberti","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.it.2006.05.007_bib17","first-page":"244","article-title":"Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion","volume":"38","author":"Barr","year":"2005","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.it.2006.05.007_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/IAI.74.1.135-143.2006","article-title":"The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi","volume":"74","author":"Hardison","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.it.2006.05.007_bib19","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.4049\/jimmunol.163.9.4642","article-title":"Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans","volume":"163","author":"Huffnagle","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2006.05.007_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/427515","article-title":"CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi","volume":"191","author":"Machado","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2006.05.007_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature02822","article-title":"Evolutionary genetics: Ambiguous role of CCR5 in Y. pestis infection","volume":"430","author":"Elvin","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.it.2006.05.007_bib22","doi-asserted-by":"crossref","first-page":"15276","DOI":"10.1073\/pnas.2435085100","article-title":"Evaluating plague and smallpox as historical selective pressures for the CCR5-\u039432 HIV-resistance allele","volume":"100","author":"Galvani","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2006.05.007_bib23","first-page":"26","article-title":"Bubonic plague and HIV. The \u039432 connection","volume":"103","author":"Goldrick","year":"2003","journal-title":"Am. J. Nurs."},{"key":"10.1016\/j.it.2006.05.007_bib24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/427606a","article-title":"Evolutionary genetics: CCR5 mutation and plague protection","volume":"427","author":"Mecsas","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.it.2006.05.007_bib25","doi-asserted-by":"crossref","unstructured":"Sabeti, P.C. et al. (2005) The case for selection at CCR5-\u039432. PLoS Biol. 3, e378 DOI: 10.1371\/journal.pbio.0030378 (http:\/\/biology.plosjournals.org)","DOI":"10.1371\/journal.pbio.0030378"},{"key":"10.1016\/j.it.2006.05.007_bib26","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1084\/jem.20042530","article-title":"Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection","volume":"202","author":"Glass","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2006.05.007_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20051970","article-title":"CCR5 deficiency increases risk of symptomatic West Nile virus infection","volume":"203","author":"Glass","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2006.05.007_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.med.57.121304.131418","article-title":"West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States","volume":"57","author":"Hayes","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.it.2006.05.007_bib29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3201\/eid1108.050289a","article-title":"Epidemiology and transmission dynamics of West Nile virus disease","volume":"11","author":"Hayes","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.it.2006.05.007_bib30","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3201\/eid1108.050289b","article-title":"Virology, pathology, and clinical manifestations of West Nile virus disease","volume":"11","author":"Hayes","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.it.2006.05.007_bib31","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","article-title":"The outbreak of West Nile virus infection in the New York City area in 1999","volume":"344","author":"Nash","year":"2001","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.it.2006.05.007_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF01718310","article-title":"West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice","volume":"141","author":"Ben-Nathan","year":"1996","journal-title":"Arch. Virol."},{"key":"10.1016\/j.it.2006.05.007_bib33","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","article-title":"Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc \u03b3 receptor-dependent and -independent mechanisms","volume":"80","author":"Chung","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2006.05.007_bib34","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2006.05.007_bib35","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+T cells in control of West Nile virus infection","volume":"78","author":"Shrestha","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2006.05.007_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/JVI.80.1.119-129.2006","article-title":"CD8+ T cells require perforin to clear West Nile virus from infected neurons","volume":"80","author":"Shrestha","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2006.05.007_bib37","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.171.5.2524","article-title":"IFN-\u03b3-producing \u03b3\u03b4 T cells help control murine West Nile virus infection","volume":"171","author":"Wang","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2006.05.007_bib38","doi-asserted-by":"crossref","first-page":"13323","DOI":"10.1128\/JVI.77.24.13323-13334.2003","article-title":"CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis","volume":"77","author":"Wang","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2006.05.007_bib39","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/nm1140","article-title":"Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis","volume":"10","author":"Wang","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2006.05.007_bib40","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","article-title":"Alpha\/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival","volume":"79","author":"Samuel","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2006.05.007_bib41","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.142287799","article-title":"Positional cloning of the murine flavivirus resistance gene","volume":"99","author":"Perelygin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2006.05.007_bib42","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1128\/JVI.80.6.2987-2999.2006","article-title":"RNase L plays a role in the antiviral response to West Nile virus","volume":"80","author":"Scherbik","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2006.05.007_bib43","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1086\/497340","article-title":"Single nucleotide polymorphisms in genes for 2\u2032-5\u2032-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection","volume":"192","author":"Yakub","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2006.05.007_bib44","doi-asserted-by":"crossref","first-page":"11457","DOI":"10.1128\/JVI.79.17.11457-11466.2005","article-title":"Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis","volume":"79","author":"Klein","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2006.05.007_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jmv.20205","article-title":"Different chemokine expression in lethal and non-lethal murine West Nile virus infection","volume":"74","author":"Shirato","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.it.2006.05.007_bib46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/13550280500384982","article-title":"Differential responses of human brain cells to West Nile virus infection","volume":"11","author":"Cheeran","year":"2005","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.it.2006.05.007_bib47","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.1101160","article-title":"The influence of CCL3L1 gene-containing segmental duplications on HIV-1\/AIDS susceptibility","volume":"307","author":"Gonzalez","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.it.2006.05.007_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molmed.2005.03.003","article-title":"CCL3L1 dose and HIV-1 susceptibility","volume":"11","author":"Mackay","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.it.2006.05.007_bib49","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1097\/00002030-200012010-00006","article-title":"Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study","volume":"14","author":"McDermott","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.it.2006.05.007_bib50","first-page":"851","article-title":"CCR5 antagonists for the treatment of HIV","volume":"5","author":"Barber","year":"2004","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.it.2006.05.007_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/095632020501600601","article-title":"CCR5 antagonists: host-targeted antivirals for the treatment of HIV infection","volume":"16","author":"Westby","year":"2005","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.it.2006.05.007_bib52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1126\/science.1099288","article-title":"Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5","volume":"306","author":"Lederman","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.it.2006.05.007_bib53","first-page":"201","article-title":"Update on HIV infection","volume":"37","author":"von Overbeck","year":"2005","journal-title":"J. Insur. Med."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490606001499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490606001499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T17:00:09Z","timestamp":1683478809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490606001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1471490606001499"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2006.05.007","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}